Antihypertensive medication use and ovarian cancer survival

CONCLUSION: Overall, we did not find clear relationships between antihypertensive medication use and ovarian cancer mortality. However, given the limitation of the data, we cannot determine whether the association may differ by type of beta-blockers. The reasons underlying the observed associations with pre-diagnostic calcium-channel blocker use and post-diagnostic ACE inhibitor use require further investigation.PMID:34556331 | DOI:10.1016/j.ygyno.2021.09.009

Source: Gynecologic Oncology - September 24, 2021 Category: Cancer & Oncology Authors: Tianyi Huang Mary K Townsend Robert L Dood Anil K Sood Shelley S Tworoger Source Type: research